Snapshot · Matt and Shane's Secret Podcast
Biohacker Brian Johnson reportedly conducted a large-dose psilocybin experiment while hooked up to advanced brain-monitoring equipment, finding significant neurological benefits.
Where this was said
At 26:25 · chapter starts 18:15
Talk of psilocybin therapy leads to Brian Johnson, the tech entrepreneur who turned his fortune into a radical anti-aging project. The optics are undeniably weird — swapping blood serum with his teenage son is, as Matt puts it, 'mirror mirror on the wall' stuff straight from a fairy tale. But Matt gives him a partial pass: Johnson publishes all his findings, which makes him more credible than the average biohacker. The detail that breaks the guys is the umbrella — Johnson reportedly won't go in direct sunlight and carries a parasol, which Matt calls 'acceptable for Asian ladies and pasty Irish people only.' More substantively, Matt mentions Johnson strapped himself to advanced brain monitoring gear while taking large doses of psilocybin, finding major neurological benefits — and potentially relevant for Nate, whose dad is developing dementia. [1] — Matt McCusker "Brian Johnson drained his son's blood plasma to inject into himself and wears an umbrella from the sun — but he also publishes all his bioh…" 24:20 Nate shares his dad's origin story: a Black Deadhead from Reading, PA who sold weed and rode motorcycles he didn't know how to ride. The crew plots a microdose intervention for the old man, with a Grateful Dead soundtrack.
Brian Johnson drained his son's blood plasma to inject into himself and wears an umbrella from the sun — but he also publishes all his biohacking data transparently. Matt McCusker coins the term 'healthy vamp' and admits he respects the hustle even if the optics are terrible.
Nate Marshall's dad was a Black Deadhead who rode motorcycles he didn't know how to ride, sold weed in Reading, PA, and was apparently the coolest dude at the Catholic school. Now he has dementia, and Nate is considering slipping him a microdose while playing the Dead.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.